Call Us Today! (603) 546-6800|
Publications and Case Reports on GlycanMap ® Technology2016-11-09T04:41:33+00:00

Below is a partial list of peer-reviewed publications relating to GlycanMap® technology.


Miura Y., Nakahara, T., McCarthy, D. “Enabling High-throughput Glycomics” Gen. Eng. News 32 (13), 2012     Download»
Perkel, J., “At last, large-scale functional glycomics”, Anal. Chem., 80, 1354–1355 (2008)
Furukawa J-i., Shinohara Y., Kuramoto H., Miura Y., Shimaoka H., Kurogochi M., Nakano M., Nishimura S.-I., “A comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion”, Anal. Chem. , 80, 1094-1101 (2008)
Miura Y., Hato M., Shinohara Y., Kuramoto H., Furukawa J.-i., Kurogochi M., Shimaoka H., Tada M., Nakanishi K., Ozaki M.,Todo S., and Nishimura S.-I., “BlotGlycoABCTM: An integrated glycoblotting technique for rapid and large-scale clinical glycomics”, Mol. Cell. Proteom. , 7, 370-377 (2008)
Kita Y., Miura Y., Furukawa J., Nakano M., Shinohara Y., Ohno M., Takimoto A., and Nishimura S.-I., “Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N- glycans”, Mol. Cell. Proteom. , 6, 1437-1445 (2007)
Miura Y., Shinohara Y., Furukawa J., Nagahori N., and Nishimura S.-I., “ Rapid and Simple Solid-Phase Esterification of Sialic Acid Residues for Quantitative Glycomics by Mass Spectrometry”, Chem. Eur. J., 13, 4797- 4804 (2007)
Niikura K., Kamitani R., Kurogochi M., Uematsu R., Shinohara Y., Nakagawa H., Deguchi K., Monde K., Kondo H., Nishimura S.-I., “Versatile Glycoblotting Nanoparticles for High Throughput Protein Glycomics”, Chem. Eur. J. , 11, 3825-3835 (2005)
Nishimura S.-I., Niikura K., Kurogochi M., Matsushita T., Fumoto M., Hinou H., Kamitani R., Nakagawa H., Deguchi K., Miura N., Monde K., Kondo H., “ High-Throughput Protein Glycomics: Combined Use of Chemoselective Glycoblotting and MALDI-TOF/TOF Mass Spectrometry”, Angew. Chem. Int. Ed., 44, 91-96 (2005)

Scientific Posters

Dang A, Stevenson T, Miura Y, Nakahara T, and Asada H. “The GlycanMap® Xpress™ Assay: Automated, High-Throughput Characterization of Glycoforms in Biotherapeutics Development” AAPS National Biotechnology Conference, May 2013, San Diego, CA
McCarthy D, Naahara T, Miura Y, Stevenson T, and Asada H. “A New Dimension in Biomarker Research: Application of the High-throughput GlycanMap® Platform to Discovery of Novel Glycomic Biomarkers” Molecular Medicine Tri-Conference, February 2013, San Francisco, CA
Stevenson T, Miura Y, Nakahara T, and Asada H. “GlycanMap® Technology, a New High-Throughput Platform for the Analysis of N-linked Glycans” Well Characterized Biologicals Conference, October 2012, Washington DC
Nakahara T, McCarthy D, Miura Y, Asada H, Opiteck G, Kelley D, Mixson L, Shearman L, Mehmet H, and Souza S. “High-throughput glycomics for discovery of cancer biomarkers” Markers in Cancer, October 2012, Hollywood, FL.
Asada H, Nakahara T, Stevenson T, and Miura Y. “Discovery and Development of Glycan Biomarkers using the High-throughput GlycanMap® Platform” 5th Biomarker Discovery and Development Conference, October 2011, San Diego, CA.
Gupta S, Gerlach J, Miura Y, Yamazaki T, Nakahara T, Asada H, Samali A, and Joshi L. “High throughput GlycanMap® analysis of glycosylation during ER stress and apoptosis in a colon cancer model” Annual Conference of the Society for Glycobiology, November 2010, St. Pete Beach, FL.
Miura Y, Baginski T, Asada H, and Keck R. “Comparison of GlycanMap® analysis, a rapid, high-throughput MALDI-TOF MS glycan analysis method, to fluorescent (2- AA) HPLC for recombinant glycoprotein characterization” CASSS Mass Spec, September 2010, Marina Del Rey, CA.
Nakahara T, Furukawa J-I, and Nishimura, S-I. “Alteration of glycan ensemble in tumor-bearing patients and rheumatoid arthritis patients” CHI Biomarker World Congress, May 2009, Philadelphia, PA.
Miura Y, Furukawa J-I, Shinohara Y, and Nishimura, S-I. “Automated, high-throughput, and quantitative serum glycomics enabled by glycoblotting technique” CHI Biomarker World Congress, May 2009, Philadelphia, PA.